Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors

Authors: Apostolos Gaitanidis, MD, Dhaval Patel, MD, Electron Kebebew, MD, FACS

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Pancreatic neuroendocrine tumors (PNETs) are rare tumors, exhibiting highly variable biological behavior, ranging from indolent to aggressive. Predicting the biological behavior of PNETs is difficult. Prognostic factors currently utilized to predict tumor progression, recurrence, or survival include tumor grade, presence of lymph node metastasis, and perineural invasion. In the majority of cases, these factors are available only after histologic examination. Therefore, novel biomarkers are needed to improve prognostic assessment in patients with PNETs to optimize management and treatment. The prognostic value of several markers of systemic inflammatory response has been suggested by several studies for different types of cancer, including neuroendocrine tumors.1 The aim of this study is to examine the potential prognostic role of markers of systemic inflammatory response in patients with PNETs. …
Literature
1.
2.
Gaitanidis A, Patel D, Nilubol N, Tirosh A, Sadowski S, Kebebew E. Markers of systemic inflammatory response are prognostic factors in patients with pancreatic neuroendocrine tumors (PNETs): a prospective analysis. Ann Surg Oncol. 2018;25:122–130.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors
Authors
Apostolos Gaitanidis, MD
Dhaval Patel, MD
Electron Kebebew, MD, FACS
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6948-x

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

ASO Author Reflections

ASO Author Reflections: Tumor Markers in Gastric Cancer

ASO Author Reflections

ASO Author Reflections: Evolving Concepts for Radiation Therapy in Extremity and Trunk Soft Tissue Sarcoma

ASO Author Reflections

ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients

ASO Author Reflections

ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma

ASO Author Reflections

ASO Author Reflections: Dialysis and Recurrence in Urothelial Cancer

ASO Author Reflections

ASO Author Reflections: Multimodal Treatment of Upper Gastrointestinal Signet Ring Cell Containing Cancer—Better Together